Diaverum
Diaverum, a leading global provider of renal care services, is headquartered in Sweden (SE) and operates extensively across Europe, Latin America, and the Middle East. Founded in 1991, the company has established itself as a key player in the dialysis industry, focusing on delivering high-quality patient care and innovative treatment solutions. Specialising in dialysis services, Diaverum offers a range of core products, including haemodialysis and peritoneal dialysis, tailored to meet the unique needs of patients. Their commitment to patient-centric care and advanced technology sets them apart in the market. With a strong emphasis on improving patient outcomes, Diaverum has achieved notable milestones, including expanding its network of clinics and enhancing service delivery. Recognised for its excellence in renal care, Diaverum continues to strengthen its position as a trusted partner in the healthcare sector, dedicated to transforming the lives of patients with chronic kidney disease.
DitchCarbon Score
How does Diaverum's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Diaverum's score of 30 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Diaverum's reported carbon emissions
In 2024, Diaverum reported total carbon emissions of approximately 30,687,000 kg CO2e, with Scope 1 emissions at about 3,507,000 kg CO2e and Scope 2 emissions (market-based) at approximately 27,180,000 kg CO2e. This marks a slight increase from 2023, where total emissions were about 30,308,000 kg CO2e, with Scope 1 emissions at around 2,274,000 kg CO2e and Scope 2 emissions (market-based) at approximately 28,034,000 kg CO2e. In 2022, Diaverum's emissions were significantly lower, totalling about 7,836,000 kg CO2e, which included Scope 1 emissions of approximately 22,000 kg CO2e, Scope 2 emissions of about 623,000 kg CO2e, and Scope 3 emissions primarily from waste generated in operations, which accounted for around 6,966,000 kg CO2e. Diaverum's emissions data is cascaded from its parent company, Diaverum Sweden AB, reflecting the organisation's commitment to transparency in its environmental impact. However, there are currently no specific reduction targets or climate pledges reported, indicating a potential area for future development in their sustainability strategy. Overall, Diaverum's emissions profile highlights the importance of addressing both direct and indirect emissions as part of their climate commitments, particularly in the context of the healthcare industry, where operational efficiencies can lead to significant reductions in carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 22,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 623,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 7,192,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Diaverum is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
